Expression Analysis of Specific Markers in Non-small Cell Lung Cancer or Melanoma

Clinical trial NCT00685750 · TERMINATED

Trial details

NCT number: NCT00685750
Sponsor: GlaxoSmithKline
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Lung Cancer, Non-Small Cell

Start date: 2008-04-28
Primary completion: 2013-12-17
Enrollment: 88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.